Treatment Intensification With Insulin Pumps and Other Technologies in Patients With Type 2 Diabetes: Results of a Physician Survey in the United States.
Treatment Intensification With Insulin Pumps and Other Technologies in Patients With Type 2 Diabetes: Results of a Physician Survey in the United States.
复制标题
DOI：
10.2337/cd19-0008
复制
发表时间：
2020-01-01
期刊：
影响因子：
--
通讯作者：
Miller, Eden M
中科院分区：
文献类型：
--
作者：
Grunberger, George;Sze, David;Miller, Eden M
进行了一项在线调查，以评估美国初级保健医生（PCP）和内分泌学家样本对糖尿病技术的观点和使用，以优化2型糖尿病患者的强化胰岛素治疗。总体而言，内分泌学家报告，对于需要基础-餐时胰岛素治疗的2型糖尿病患者，使用糖尿病技术的频率高于PCP。高度关注胰岛素治疗的糖尿病管理的PCP和内分泌学家报告说，当患者在每天接受基础胰岛素加三次或更多次餐时注射胰岛素而未达到A1 C目标时，使用胰岛素输送装置（胰岛素泵和可穿戴无管贴片）。
An online survey was conducted to assess the perspectives and use of diabetes technologies by a sample of U.S. primary care physicians (PCPs) and endocrinologists to optimize intensive insulin therapy in patients with type 2 diabetes. Overall, endocrinologists reported using diabetes technologies more frequently than PCPs for patients with type 2 diabetes requiring basal-bolus insulin therapy. PCPs and endocrinologists who were highly focused on diabetes management with insulin therapy reported using insulin delivery devices (insulin pumps and wearable tube-free patches) when patients are not achieving their A1C target while taking basal plus three or more prandial injections of insulin daily.